Kestra Medical Technologies, Ltd. Payments of Stock Issuance Costs
Kestra Medical Technologies, Ltd. (KMTS) reported Payments of Stock Issuance Costs of $415.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. payments of stock issuance costs for the quarter ending 2026-07-31 was $415.00K.
- Kestra Medical Technologies, Ltd. payments of stock issuance costs for the quarter ending 2026-04-30 was $480.00K.
- Kestra Medical Technologies, Ltd. payments of stock issuance costs for the quarter ending 2026-01-31 was $84.00K, a 21.74% increase year-over-year.
- Kestra Medical Technologies, Ltd. payments of stock issuance costs for the quarter ending 2025-04-30 was -$69.00K.
- Kestra Medical Technologies, Ltd. payments of stock issuance costs for fiscal 2026 was $2.47M, a 23.51% decline from fiscal 2025.
- Kestra Medical Technologies, Ltd. payments of stock issuance costs for fiscal 2025 was $3.22M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-07-31 | $415.00K 10-Q · filed 2026-09-14 | $895.00K derived: sum of 2 quarters · filed 2026-09-14 | $979.00K derived: sum of 3 quarters · filed 2026-09-14 | |
| 2026-04-30 | $480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $564.00K derived: sum of 2 quarters · filed 2026-07-14 | $2.47M 10-K · filed 2026-07-14 | |
| 2026-01-31 | $84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $1.99M 10-Q · filed 2026-03-17 | ||
| 2025-10-31 | $1.90M 10-Q · filed 2025-12-11 | |||
| 2025-04-30 | -$69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $0.00 derived: sum of 2 quarters · filed 2026-07-14 | $0.00 derived: sum of 3 quarters · filed 2026-07-14 | $3.22M 10-K · filed 2026-07-14 |
| 2025-01-31 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $69.00K derived: sum of 2 quarters · filed 2026-03-17 | $3.29M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | $3.22M 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $3.22M 10-Q · filed 2025-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |